Found 4 bookmarks
Custom sorting
THERAPEUTIC AGENT FOR INFECTIOUS SKIN OR MUCOSAL DISEASE - European Patent Office EP2133083 A1 - EP2133083A1.pdf
THERAPEUTIC AGENT FOR INFECTIOUS SKIN OR MUCOSAL DISEASE - European Patent Office EP2133083 A1 - EP2133083A1.pdf
****!!!!*** [Taiko] "chlorine dioxide, which can cure an intractable skin disease, such as skin disease caused by humanpapilloma virus, against which no effective therapeutic method had been developed" "sodium dihydrogenphosphate as the pH adjuster whose pH is 2.5 to 6.8 as a 5% aqueous solution at 25°C, ****remarkably enhances**** the preservation stability of the chlorine dioxide solution"
·patentimages.storage.googleapis.com·
THERAPEUTIC AGENT FOR INFECTIOUS SKIN OR MUCOSAL DISEASE - European Patent Office EP2133083 A1 - EP2133083A1.pdf
Fungal cream-Treatment for candidia infections ~Patent
Fungal cream-Treatment for candidia infections ~Patent
****!!!!****{Doses & studies for skin (& maybe internal?) treatments} " treating fungal infections using a metal salt of chlorite alone or in combination with a conventional antifungal agent... topical or systemic."*****[? Statements need verification] "chlorite ions are many times less toxic than chlorine dioxide to animal cells and that maintaining it at a higher pH will allow for a higher concentrations to be used. Concentrations of up to 0.5% in internal fluids have been shown to be acceptable for internal use. Higher dosages are likely to be acceptable also. External use allows for considerably higher concentrations to be used, and even higher concentrations are acceptable for short-term contact." "A pattern observed indicates that sodium chlorite alone at a pH that does not create chlorine dioxide and in combination with conventional antifungal agents is a superior antifungal agent than the antifungal alone against 100% of fungi tested."
·patents.google.com·
Fungal cream-Treatment for candidia infections ~Patent
A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055 [formerly known as TCDO]) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan
A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055 [formerly known as TCDO]) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan
****!!!!**** "In case of clinically diagnosed wound infections, topical wound disinfection was allowed for 5 consecutive days with saline containing 970 ppm chlorine dioxide... wound cleansing and disinfection with gauzes soaked in physiological saline solution containing 320 ppm chlorine dioxide... for 15 minutes... In CL endemic regions with poor infrastructure, bipolar HF-EC is a robust technology to debride CL lesions under local anaesthesia. The combination with DAC N-055 MWT provides additional anti-parasitic, antimicrobial and wound healing effects."
·ncbi.nlm.nih.gov·
A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055 [formerly known as TCDO]) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan